Caris Life Sciences—an Irving-based leader in precision oncology that filed for an initial public offering last month—plans to raise as much as $423.5 million when it goes public on the Nasdaq Global ...

National nonprofit The Trust for Public Land has launched the Greener Dallas Greater Dallas Campaign, a $100 million public-private campaign to expand parks citywide that will serve more than 250,000 ...

A crisis has been unfolding in Dallas for more than a decade that is now reaching an inflection point: Economic growth will not continue without closing the housing affordability gap. That was the ...

Dallas-based biotech company Signify Bio has launched with an oversubscribed $15 million initial financing round. The round was led by by Actium Group with participation from the Gates Foundation ...

The new plant in Mesquite—the first in North America for Xiamen, China-based Hithium—is slated to begin mass production in late 2025, with an annual capacity of 10GWh for battery modules and systems.

The Last Word: Colossal Biosciences’ Ben Lamm on Science, Skeptics, and the Sound of a Howl In one of his first deep interviews since Colossal's dire wolf debut made global noise, Ben Lamm joins the ...

Irving-based Kimberly-Clark (NASDAQ: KMB) is spinning off a majority stake in its international tissue business by forming a joint venture with Sao Paolo, Brazil-based Suzano (NYSE: SUZ).The deal will ...

A new firm has been launched in the Dallas Design District by award-winning architects Sarah Harper and Richard Drummond Davis. Harper + Drummond Davis Architects is a full-service architectural firm ...